Short title: Expression and function of P2X 7 receptors P2X 7 receptors are important in mediating the physiological functions of extracellular ATP, and altered receptor expression and function have a causative role in the disease pathogenesis. Here we investigated the mechanisms determining the P2X 7 receptor function by following two human SNP mutations that replace H155 and A348 in the hP2X 7 receptor with the corresponding residues Y155 and T348 in the rP2X 7 receptor. H155Y and A348T mutations in the hP2X 7 receptor increased ATP-induced currents, whereas the reciprocal mutations Y155H and T348A in the rP2X 7 receptor caused the opposite effects. Such functional switch is a compelling indication that these residues are critical for the P2X 7 receptor function. Additional mutations of H155 and A348 in the hP2X 7 receptor to residues with diverse side-chains reveal different dependence on the side-chain properties, supporting specificity of these two residues. Substitutions of the residues surrounding H155 and A348 in the hP2X 7 receptor with the equivalent ones in the rP2X 7 receptor also affected ATP-induced currents, but were not fully reminiscent of the H155Y and A348T effects. Immunofluorescent imaging and biotin-labelling assays showed that H155Y in the hP2X 7 receptor increased, whereas Y155H in the rP2X 7 receptor decreased, cell surface expression. Such contrasting effects were not obvious with the reciprocal mutations of residue 348. Taken together, our results suggest that residues at positions 155 and 348 contribute to P2X 7 receptor function via determining the surface expression and the single channel function respectively. Such interpretations are consistent with the location of the residues in the structural model of the hP2X 7 receptor.
P2X 7 receptors are important in mediating the physiological functions of extracellular ATP, and altered receptor expression and function have a causative role in the disease pathogenesis. Here we investigated the mechanisms determining the P2X 7 receptor function by following two human SNP mutations that replace H155 and A348 in the hP2X 7 receptor with the corresponding residues Y155 and T348 in the rP2X 7 receptor. H155Y and A348T mutations in the hP2X 7 receptor increased ATP-induced currents, whereas the reciprocal mutations Y155H and T348A in the rP2X 7 receptor caused the opposite effects. Such functional switch is a compelling indication that these residues are critical for the P2X 7 receptor function. Additional mutations of H155 and A348 in the hP2X 7 receptor to residues with diverse side-chains reveal different dependence on the side-chain properties, supporting specificity of these two residues. Substitutions of the residues surrounding H155 and A348 in the hP2X 7 receptor with the equivalent ones in the rP2X 7 receptor also affected ATP-induced currents, but were not fully reminiscent of the H155Y and A348T effects. Immunofluorescent imaging and biotin-labelling assays showed that H155Y in the hP2X 7 receptor increased, whereas Y155H in the rP2X 7 receptor decreased, cell surface expression. Such contrasting effects were not obvious with the reciprocal mutations of residue 348. Taken together, our results suggest that residues at positions 155 and 348 contribute to P2X 7 receptor function via determining the surface expression and the single channel function respectively. Such interpretations are consistent with the location of the residues in the structural model of the hP2X 7 receptor. P2X 7 receptors belong to the ionotropic purinergic P2X receptor family (1) (2) (3) (4) (5) . The receptor expression is well documented in immune cells, glial cells in the brain, satellite cells in the peripheral nervous system, bone, and epithelial cells, where the receptor serves as the primary mediator for numerous physiological functions of extracellular ATP, including immune responses, inflammation, cell proliferation, neuron-glia interactions, nociception, bone remodelling, and saliva secretion (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . The receptor is thought to be a homo-trimer (18) with three subunits intertwining together along a vertical ion conducting pathway. Each subunit contains two transmembrane domains (TM1 and TM2) joined by a large ectodomain and both N-and C-termini reside intracellularly. Functional characterizations of mammalian P2X 7 receptors have identified several distinguishing features, including activation by sub-mM concentrations of ATP and a higher sensitivity to BzATP, a synthetic ATP analogue, than ATP (19) (20) (21) . In addition to operating as ATP-gated Ca 2+ -permeable cation channels that open within milliseconds upon agonist binding, P2X 7 receptors induce formation of a large pore, activation of the inflammasome and numerous other downstream signalling events in response to prolonged stimulation (1, (19) (20) (21) (22) .
The functional expression level of P2X 7 receptor is crucial in its role in the disease pathogenesis. This has been highlighted by an increasing number of findings that aberrant or altered receptor expression and function have a causative role in chronic lymphocytic leukaemia (23) (24) (25) , reduced bacterial killing ability of macrophages (26) (27) , impaired release of cytokines (6, (28) (29) (30) , inflammatory and neuropathic pain (11, 16) , rheumatoid arthritis (7), neurodegenerative and neuroinflammatory disorders (13, 14, (31) (32) (33) (34) (35) (36) , mood depressive disorders (37) (38) (39) (40) and epithelial cancers (41) (42) (43) . Studies of the mammalian P2X 7 receptors, and particularly the human (h) and rat (r) P2X 7 receptors, have revealed striking species differences in the receptor properties, including receptormediated functional responses and sensitivities to agonists, antagonists, and modulators (19) (20) (21) (44) (45) (46) (47) (48) (49) (50) (51) (52) . However, the physiological implications and underlying mechanisms are still not well understood.
Our recent study characterizing the mutations resulting from non-synonymous single nucleotide polymorphisms (ns-SNP) in the human P2RX7 gene has shown that H155Y and A348T mutations increase ATP-induced currents (52) . These two gain-of-function mutations substitute the residues in the hP2X 7 receptor with the corresponding ones in the rP2X 7 receptor. Here we show evidence for a critical role of residues at positions 155 and 348 in determining the ATP-induced currents mediated by human and rat P2X 7 receptors, and distinct mechanisms that underlie their contribution.
MATERIALS AND METHODS
Cell and molecular biology --Human embryonic kidney (HEK293) cells were used to transiently express wildtype (WT) and mutant P2X 7 receptors. Cell preparation and transfection using lipofectamine2000 reagents (Invitrogen) were performed according to the manufacturer's instructions. In brief, for patch-clamp recordings, HEK293 cells in a 35 mm petridish were co-transfected with 1 μg of P2X 7 plasmid and 0.1 μg of enhanced green fluorescent protein (GFP) plasmid, or otherwise as specifically indicated. Cells were dispersed on coverslips 12-24 hr after transfection, and used within 48 hr. The transfection efficiency, estimated based on the GFP-positive cells, was >50% and single cells with similar GFP expression levels were used. For biotin-labelling and immunostaining, HEK293 cells were transfected in the same way except for omission of GFP plasmid for immunostaining experiments. The cDNAs encoding the rP2X 7 (Swiss-Prot No Q64663) and hP2X 7 protein (Q99572) with a C-terminal EYMPME (EE) epitope were inserted in pcDNA3 or pcDNA3.1 vectors (Invitrogen). Mutations were introduced by site-directed mutagenesis and confirmed by sequencing.
Patch-clamp recording --Whole-cell currents were recorded at room temperature as previously described (54) using an HEKA EPC10 amplifier at a holding potential of -60 mV. Normal extracellular solution contained (concentrations in mM): 147 NaCl, 2 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 HEPES and 13 glucose, pH 7.3. The maximal currents induced by applying 5-10 mM ATP to cells expressing P2X 7 receptors were not readily observed in the normal solution (53) and therefore most experiments were carried out in low divalent cation extracellular solution containing no MgCl 2 and 0.3 mM CaCl 2 . Intracellular solution contained (in mM): 145 NaCl, 10 EGTA and 10 HEPES, pH 7.3. The currents were compared upon full facilitation (51) by repeated applications of submaximal concentrations of agonist every 1 min. Bisperoxo(1,10-phenanthroline)oxovanadate (V) (100 μM) was used to mitigate current decline in some experiments (55) . The concentration-current response curves shown in the figures were constructed using the recordings that showed <10% decline in the currents induced by the same concentration of agonists used for facilitation, before and after measuring the concentration-current responses. To examine each subset of mutations, only the data for the WT receptor obtained in parallel experiments were used for comparison. To test KN-62 antagonist, currents induced by 1 mM ATP, when reproducible, were exposed to each accumulative concentration for 4 min. The ATP concentration-current responses were also measured before and 4 min after exposure to 100 nM KN-62. Agonists and antagonists were delivered using a RSC160 system (Bio-Logic Instruments, France).
Structural modelling --The structural model of the hP2X 7 receptor was generated based on the crystal structure of the zebrafish P2X 4 receptor (PDB accession 3H9V) (56). As we have described recently (53) , the modelling was carried out using Modeller version 8.2 (57) . The non-conserved loop region between β2 and β3 strands was modelled de novo using the ModLoop server (58, 59) . Images were generated using UCSF Chimera v1.4 (60) .
Immunofluorescent confocal imaging --These experiments were carried out as detailed previously (61, 62) . To examine the subcellular distribution of the WT and mutant P2X 7 receptors proteins, cells were stained with primary rabbit anti-EE antibody (1:500 or 1:000 dilution; Bethyl) for 2-3 hr (or overnight at 4°C) and Alexa Fluor 488-conjugated secondary anti-rabbit IgG antibody (1:4000 or 1:500; Molecular Probes) for 1-2 hr. To examine the co-localization of hP2X 7 Biotin-labelling and Western blotting --Biotin-labelling was performed by modifying the protocols described previously (62, 63) . In brief, cells transfected with P2X 7 plasmid, or an empty vector, and GFP plasmid were labeled with sulfo-NHS-LC-biotin (Pierce) for 30 min at 4ºC. Total protein concentrations of the cell lysates were determined using the BCA (bicinchoninic acid) assay (Thermo Scientific). The biotinylated proteins were purified from total 300 μg lysates using EZ view red streptavidin affinity beads (Sigma) overnight at 4ºC and eluted in 50 μl electrophoresis sample buffer (6% SDS, 10% glycerol, 50 mM Tris-HCl pH 6.8, 2 mM EDTA, 0.05% bromophenol blue and 10% β-mercaptoethanol). Whole cell lysate (5 or 10 μg) or biotin-labeled samples (20 μl) were separated on 12% SDS-PAGE gels. Proteins were detected using primary rabbit anti-EE antibody (1:5000; Bethyl) or mouse anti-GFP (1:2000; Santa Cruz) antibodies and horse radish peroxidase-conjugated secondary antirabbit (1:5000) or anti-mouse IgG (1:2000) antibodies (Santa Cruz), and visualized using supersignal west femto maximum sensitivity substrate (Thermo Scientific).
Data analysis --All results, where appropriate, are presented as mean ± s.e. mean values. All the currents are presented as current density, i.e., the currents divided by the cell capacitance, to minimize the effects of the variation in cell size. Agonist EC 50 values were determined by least squares fitting of the data from individual cells to the Hill equation:
n ], where I is the peak current density evoked by given agonist concentrations ([A]), I max is the maximum current density, and n is the Hill coefficient. n ], where I is the ATPinduced currents after exposure to given concentrations of antagonist ([B]) expressed as percentage of the control currents before antagonist application, and n is the Hill coefficient. Curve fits were performed using Origin software. Statistical analysis was carried out, using Student's t-test for two groups and one-way ANOVA test for more than two groups, and the difference is considered to be significant with p<0.05.
RESULTS

Initial comparison of human and rat P2X 7 receptor-mediated ATP-induced currents
ATP is the physiological agonist for all P2X receptors including the P2X 7 receptor. Fig.1A shows representative currents responses of cells expressing WT human and rat P2X 7 receptors to the indicated concentrations of ATP recorded in low divalent cation extracellular solution (see Materials and Methods). Two differences are discernible.
Firstly, the hP2X 7 receptor was less sensitive to ATP than the rP2X 7 receptor, with EC 50 values of 304 ± 49 μM (n = 5) and 110 ± 6 μM (n = 5, p<0.01) for human and rat receptors, respectively (Fig.1B) . Secondly, the amplitude of currents mediated by the hP2X 7 receptor was lower than that of the rP2X 7 receptor. The average current density evoked by the maximal concentration of ATP (I max ) was 281 ± 18 pA/pF (n = 5) for the hP2X 7 receptor, corresponding to approximately 60% of the value of 458 ± 27 pA/pF (n = 5; p<0.001) obtained for the rP2X 7 receptor (Fig.1C) . These results provide an initial indication of significant functional differences between these two receptors.
Reciprocal substitution of residues at positions 155 and 348 in human and rat P2X 7 receptors
To test whether residues at positions 155 and 348 are involved in determining the P2X 7 receptor function and particularly the difference between human and rat receptors, we compared the ATP-induced currents mediated by human and rat P2X 7 receptors bearing reciprocal mutations in low divalent cation extracellular solution. Fig.2A shows representative ATP-induced currents in cells expressing the hP2X 7 WT or mutant receptors. The A348T and H155Y mutations caused little or no change in the ATP sensitivity of the receptor (Fig.2B) . However, the ATP-induced I max increased from 268 ± 12 pA/pF (n = 29) for the WT to 391 ± 19 pA/pF (n = 10, p<0.001) for the H155Y mutant and 324 ± 17 pA/pF (n = 12, p<0.05) for the A348T mutant (Fig.2C) . These results confirmed our recent report that both the H155Y and A348T mutations increase hP2X 7 -mediated ATPinduced responses (53) . The ATP-induced I max was further increased by the double mutation H155Y/A348T (473 ± 31 pA/pF, n = 7; p<0.001); the increase was significantly greater than that produced by the single mutations (Fig.2C ). conditions, resulting from expression of the rP2X 7 WT, Y155H, T348A or Y155H/T348A mutant receptors. The T348A mutation did not alter the ATP sensitivity, while the Y155H and Y155H/T348A mutations caused small reductions (approximately 3-and 5-fold increase in the EC 50 value, respectively; Fig.3B ). The most prominent mutational effect was that the ATP-induced I max was strongly attenuated from 444 ± 24 pA/pF (n = 10) for the WT to 211 ± 25 pA/pF (n = 7, p<0.001) for the Y155H mutant and 326 ± 23 pA/pF (n = 7, p<0.01) for the T348A mutant (Fig.3C) . The ATP-induced I max was further reduced by the double mutation Y155H/T348A (114 ± 18 pA/pF, n = 3; p<0.001); the reduction was significantly greater than that yielded by the single mutations (Fig.3C) . We also examined ATPinduced currents mediated by the rP2X 7 WT, Y155H, and T348A mutant receptors in a solution with normal extracellular divalent cation concentrations (see Materials and Methods). The reduction in the ATP-induced I max caused by the Y155H and T348A mutations was also clear under these conditions (Fig.S1 ), in striking contrast with the increase in the ATP-induced I max resulting from the H155Y and A348T mutations in the hP2X 7 receptor under the same conditions, as reported in our recent study (53) . These contrasting effects were also apparent in terms of BzATP-induced currents. The H155Y and A348T mutations in the hP2X 7 receptor increased, whereas the reciprocal Y155H and T348A mutations in the rP2X 7 receptor reduced, the BzATP-induced I max (Fig.S2 ).
All these results consistently indicate that reciprocal mutations of residues at positions 155 and 348 essentially switched the agonistinduced current responses mediated by the human and rat P2X 7 receptors. Such findings strongly suggest a critical role for these two residues in determining the P2X 7 receptor function, and in particular the difference in the current responses between human and rat receptors.
Further substitution of H155 and A348 residues in the hP2X 7 receptor To gain more insight into the role of residues at positions 155 and 348 and to test the importance of the side-chain, we mutated H155 and A348 in the hP2X 7 receptor to residues with side-chains that have diverse properties (small, lengthy, bulky, neutral, negatively-or positively-charged). Fig.4 shows representative ATP-induced currents and the concentration-response curves in cells expressing the hP2X 7 receptors carrying mutations of H155 (Fig.4A-B) and A348 ( Fig.4C-D) , respectively. Overall, there was no or small change in the ATP sensitivity for all mutants ( Fig.4B and D) . The ATP-induced I max was reduced by the H155L and H155D mutations, but not changed by the H155A, H155N, H155R and H155F mutations (Fig.4E) . In contrast, the ATP-induced I max was significantly altered by each residue substituted for A348 (Fig.4F) . While the effects of mutations showed no clear relationship to the size of the residues introduced into H155 (Fig.4E) , there was an apparent correlation between the effects of mutations and the volume of the residues used to replace A348 (Fig.4F ): the one with the smallest side-chain (A348G) conferred the greatest increase, while the larger side-chains (A348M and A348F) caused the greatest decrease, in the ATP-induced I max . These results show strong dependence of the effects of mutations on the side-chains, suggesting that the side-chain properties of residues at positions 155 and 348 are critical in determining the P2X 7 receptor function.
Substitutions of residues surrounding H155
and A348 in the hP2X 7 receptor Several residues, surrounding positions 155 and 348, are different between the human and rat P2X 7 receptors (Fig.5A) . To investigate whether any of these residues have a similar role, we individually replaced the residues in the hP2X 7 receptor with the corresponding ones in the rP2X 7 receptor and examined the effects on the ATP-induced currents. Swapping residues in the region surrounding H155 resulted in six mutants: V153I, V154P, E156D, G157Q, N158K and Q159R. Fig.6A shows their ATP concentration-response curves (representative currents in Fig.S3A ). The G157Q and Q159R mutations reduced, while the other mutations did not alter, the ATP-induced I max . We also introduced tyrosine into positions 154 and 156, flanking H155. Fig.6B shows the results (representative currents in Fig.S3B ). Unlike H155Y, the V154Y mutation had no effect on, whereas the E156Y mutation strongly decreased, the ATPinduced I max (Fig.6D) . These results indicate that none of these mutations mimics H155Y or that none of these residues has a role similar to that of H155. Fig.6C summarizes the results from swapping the four residues in the region surrounding A348 (representative currents in Fig.S3C ). The F350C and L354I mutations were without effect. However, the D356N mutation reduced, while the F353L mutation increased, the ATP-induced I max (Fig.6D) . Introduction of the reciprocal L353F mutation into the rP2X 7 receptor, however, had no significant effect (data not shown). Taken together, the results from these experiments suggest that H155 and A348 and also some surrounding residues, including E156, G157, Q159, F353 and D356, is involved in determining the hP2X 7 -mediated ATP-induced current responses. However, only residues at positions 155 and 348 are critical for the difference between human and rat P2X 7 receptors.
Effects of mutating residues at 155 and 348 on cell surface expression of the P2X 7 receptors
Whole-cell ionic currents are governed by two distinctive factors: the number of functional channels at the cell surface (surface expression) and the single channel function (conductance and opening probability) (65) . We therefore investigated whether residues at positions 155 and 348 are important in determining the surface expression of human and rat P2X 7 receptors. Using immunofluorescent confocal imaging, we compared the subcellular distribution of the human and rat WT and mutant receptors containing reciprocal mutations of residues at these two positions. Fig.7A shows representative results. The immunoreactivity for the hP2X 7 WT proteins was highly diffused. This diffuse distribution was largely retained for the A348T mutant. In contrast, the immunoreactivity for the H155Y mutant was highly enriched on or near the cell surface (left column in Fig.7A ). On the other hand, the immunoreactivity for the rP2X 7 WT were principally located within or in close vicinity of the plasma membrane as we reported previously (54, 66) . Such membranerestricted immunostaining was strongly disrupted by the Y155H mutation and only slightly reduced by the T348A mutation (right column in Fig.7A ).
To further examine the effects of mutations on cell surface expression, we used biotinlabelling and Western blotting to analyse surface and total protein expression of the human and rat WT and mutant P2X 7 receptors. Fig.7B shows representative results. The H155Y mutation increased the surface protein expression (top panel), and also increased the total protein expression (bottom panel), of the hP2X 7 receptor. However, there was no change in the control GFP protein expression (bottom panel). We also examined the H155N mutation, which did not change the ATPinduced I max (Fig.4E) , and found that the H155N mutation, unlike H155Y, had no effect on the surface and total protein expression (Fig.S4 ). In contrast with the H155Y mutation in the hP2X 7 receptor, the reciprocal Y155H mutation strongly reduced the surface protein expression and, to a lesser degree, the total protein expression, of the rP2X 7 receptor (Fig.7B) . However, such contrasting changes in the surface and total protein expression were not observed for the A348T mutation in the hP2X 7 receptor and the T348A mutation in the rP2X 7 receptor (Fig.7B) , consistent with the immunostaining results (Fig.7A) .
Therefore, our results show that the H155Y mutation in the hP2X 7 receptor enhanced the surface expression of the protein and conferred a subcellular distribution close to the rP2X 7 WT receptor. Conversely, the reciprocal mutation Y155H in the rP2X 7 receptor decreased the surface expression and resulted in a subcellular distribution that was similar to the hP2X 7 WT receptor. There was no such effect on both subcellular distribution and surface expression by the reversal mutations of residues at position 348. These results, together with the effects of mutations on the ATP-induced I max , imply an important role for residue 348 in determining the single channel function, and provide direct evidence to support a critical role for residue 155 in the surface expression. As discussed below, such interpretations are consistent with the structural model of the hP2X 7 receptor, based on the recently published crystal structure of the zebrafish P2X 4 receptor (55). 7 receptor proteins Immunofluorescent confocal imaging shows extensive intracellular location of the hP2X 7 receptor proteins (Fig.7A) . To investigate which subcellular compartments they might be located, we performed double immunostaining of hP2X 7 proteins and intracellular organelle marker proteins. Fig.8 shows representative confocal images. There was strong colocalization of the hP2X 7 proteins with calreticulin, an ER protein marker (Fig.8A ), but not with TGN46, a trans-Golgi network protein marker (Fig.8B) . In addition, the immunoreactivity for the hP2X 7 proteins exhibited no apparent co-localization with the co-expressed GFP-LAMP1, a protein localized to the late endocytic compartments and lysosomes (Fig.6S) . These results indicate that the intracellular hP2X 7 proteins mainly reside within the ER.
Subcellular localization of intracellular hP2X
DISCUSSION
By combining site-directed mutagenesis with whole-cell current patch-clamp recording and protein expression assays, we show that the residues at positions 155 and 348 is critical in determining ATP-induced currents mediated by P2X 7 receptors, as well as the difference between the human and rat receptors. We provide further evidence to suggest that distinct molecular mechanisms underlie their contribution.
Importance of residues at positions 155 and 348 in determining the P2X 7 receptor function
The gene encoding the hP2X 7 receptor has extensive SNPs (650 in total as of today), including many non-synonymous ones, several of which have been shown to alter the receptor functions (23-24,26-29,53-55,61,64,67-78). H155Y and A348T are unique in that both mutations change residues in the hP2X 7 receptor to the corresponding ones in the rP2X 7 receptor (Fig.5A) . Interestingly, these two mutations confer gain of function (53,67) (Fig.2) , hinting that Y155 and T348 may contribute to the greater currents mediated by the rP2X 7 receptor than those by the hP2X 7 receptor (Fig.1) . The results from studying the human and rat P2X 7 receptors bearing the reciprocal mutations show that such swapping of residues at positions 155 and 348 results in opposite effects on the ATP-induced I max (Figs.2-3) , providing compelling evidence to indicate that the residues at positions 155 and 348 are important in determining the human and rat P2X 7 receptor functions.
The effects of mutating H155 on the ATPinduced I max clearly depend on the introduced residues but there was no clear correlation between the side-chain properties of the residues and the functional phenotypes (Fig.4E) . For example, phenylalanine (F) also contains a bulky side-chain but failed to mimic tyrosine (Y) (Fig.4E) . In contrast, the effects of mutating A348 on the ATP-induced I max showed clear correlation with the side-chain size of the introduced residues (Fig.4F) . Swapping of residues surrounding H155 and A348 identified several other residues including E156, G157, Q159, F353 and D356 that influence the hP2X 7 -mediated ATPinduced currents, but none of these mutations were fully reminiscent of H155Y and A348T (Fig.6D) . These results show that the unique location and properties of the residues at positions 155 and 348 are critical in determining the P2X 7 receptor function.
Distinct mechanisms underlying the contribution of residues at positions 155 and 348
Identification of residues 155 and 348 adds to the growing list of residues that contribute to determination of the P2X 7 receptor functional properties but only in a few cases the underlying mechanism is clearly understood (23, (26) (27) (28) (29) (53) (54) (55) 61, 64, (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) . As mentioned above, the maximal agonist-induced wholecell currents, which are widely used to indicate the functional expression of an ion channel, are determined both by the surface expression (channel number) and the single channel function (conductance and opening probability) (64) . Structural information proves powerful in helping to infer a mechanistic understanding of the P2X receptor functions from determined mutational effects, as we have recently reviewed (5) . According to the structural model of the hP2X 7 receptor on the basis of the crystal structure of the zebrafish P2X 4 receptor (56) (Fig.5) , H155 is in the extracellular domain and is positioned at the periphery of the receptor complex and well away from the inter-subunit ATP-binding site that contains the key residues K64 and K311 (5, 68) (Fig.5B-C) .
Consistent with this, mutating H155 to residues with diverse sidechain properties, despite significant alterations in the ATP-induced I max , had no or small effect on the ATP sensitivity (Fig.4B) . In addition, the H155Y mutant receptor exhibited virtually the same sensitivity to the hP2X 7 -specific antagonist KN-62 (44) as the WT (IC 50 : 127 ± 38 nM, n = 3 for the WT and 129 ± 20 nM, n = 3 for the H155Y mutant; p>0.1). Furthermore, KN-62 at 100 nM resulted in almost identical inhibition of the ATP-induced currents mediated by the WT and H155Y mutant receptors (Fig.5S) . These results strongly support the conclusion that the H155Y mutation causes no major changes in the global conformation, and particularly the ligand-binding sites, of the receptor. Moreover, the location of H155 is distant from the ion permeation pathway (Fig.5B) . Thus the functional results and structural considerations consistently disfavor significant involvement of residue 155 in determining the single channel function, and instead, point to a role in the cell surface expression of the receptor. Indeed, despite no indication of a change in the surface expression in a previous study using immunofluorescence flow cytometry (67), our immunofluorescent confocal imaging and biotin-labelling studies clearly show that the H155Y mutation increases the surface expression of the hP2X 7 receptor, whereas the reciprocal mutation, Y155H, reduces the surface expression of the rP2X 7 receptor (Fig.7) . These results provide compelling evidence to support a role for residue 155 in determining the surface expression of the P2X 7 receptors. Residue 155 is expected to be located in the lumen of the ER and the TGN before the receptor is inserted into the plasma membrane or inside the endosomes and lysosomes after retrieval from the cell surface. Our immunostaining results indicate that the intracellular hP2X 7 proteins mainly reside in the ER (Fig.8) . Thus, one simple and consistent interpretation is that residue 155 is critical in the P2X 7 protein folding in the ER, resulting in the P2X 7 receptors that are either transported from the ER to the plasma membrane or retained in the ER and degraded. This can also explain that mutation of residue 155 altered the total protein expression level (Fig.7) . However, we cannot exclude other possibilities such as altered protein synthesis or mRNA stability.
On the other hand, the model predicts A348 to be part of intracellular pore and close to the physical gate that occludes the ion permeating pathway in the closed state (5,56) (Fig.5D) , a position well purported for A348 to have a role in the channel gating and conductance. A recent study has proposed that a significant narrowing of the intracellular pore occurs during the P2X receptor channel opening (79) . This notion is concordant with the strong correlation of the effects of mutating A348 on the ATP-induced I max with the side-chain volume or size of the introduced residues (Fig.4F) . The immunofluorescent confocal imaging and biotin-labeling results (Fig.7) largely rule out a significant contribution of residue 348 to cell surface expression, and indirectly support a more important role in determining the single channel properties.
Taken together, our results suggest distinct mechanisms underlying the contribution of residues at positions 155 and 348 to the P2X 7 receptor function: an important role for residue 155 in the surface expression and a predominant role for residue 348 in the single channel function. Further studies are required to better understand these specific roles.
Physiological and pathological implications
The expression and function of P2X 7 receptor are vital to its role in mediating the functions of extracellular ATP (see Introduction). As mentioned earlier, the H155Y and A348T mutations result from ns-SNPs in the human P2RX7 gene. A very recent study shows that monocytes from individuals with haplotypes of the hP2X 7 receptors carrying A348T exhibit increased ATP-induced secretion of interleukin-1β (78), a pro-inflammatory cytokine that is important in the pathological roles of the P2X 7 receptors (13, 14, 80, 81) . As demonstrated in the present study, the strong difference in hP2X 7 receptor function (Fig.3) , depending on which residues at positions 155 and 348 individuals carry, is expected to confer differential susceptibilities to diseases. Genetic linkage evidence for disease association of these two ns-SNPs has not yet come forward. However, a previous study reported a trend for linkage of the A348T SNP with the severity of the anxiety disorders (39) . Clearly, the results reported and the concepts formulated here should facilitate future genetic linkage studies and therapeutic exploitations (82) (83) (84) . This study, as far as we are aware, provides the first insight into the molecular mechanisms controlling the species difference in the P2X 7 receptor functions. Such and other differences in the receptor properties (see Introduction) may call for cautions to be exercised when the functional roles of the hP2X 7 receptor are inferred from studies using laboratory animals.
In conclusion, we show that residues at positions 155 and 348 are important in determining the P2X 7 receptor function and contribute to the difference in ATP-induced responses between the human and rat receptors. We provide evidence to suggest that distinct mechanisms underlie the contribution of these two residues. Such insight into mechanisms controlling the P2X 7 receptor functions will help to evolve a better understanding of the important and diverse roles for this receptor in mediating an increasing number of physiological and pathological functions of extracellular ATP. The dotted lines denote the mean maximal currents for the WT hP2X 7 receptor in parallel experiments. ***, p<0.001, **, p<0.01 and *, p<0.05, compared to the WT hP2X 7 receptor (t-test). In F, # indicates that A348G differs from WT, A348M and A348F; A348T differs from A348M and A348F; A348M differs from A348G and A348T; and A348F differs from A348G and A348T (one-way ANOVA test, p<0.05). The solid line shows a linear fit, and the R value is 0.7.
Fig.5 The structural model of hP2X 7 receptors and the locations of H155 and A348
A. The dolphin-shaped structural model of a single hP2X 7 subunit, with the residues surrounding residues at positions 155 and 348 highlighted in purple and those under investigation denoted in bold in the sequences. B. The trimeric complex of hP2X 7 receptor, with three different subunits in blue, green and red, respectively. H155 and A348 are shown in orange. Residue K64 in purple and K311 in yellow represent the key residues in the inter-subunit ATP binding site. The structures in A-B are viewed parallel to the membrane plane. C. A snapshot of the structure surrounding H155, viewed from along the axis of three-fold symmetry from the extracellular side. H155 is distant from the ATP-binding site. D. A snapshot of the structure surrounding A348, viewed from along the axis of three-fold symmetry from the intracellular side. TM2 contributes the ion conducting pathway and TM1 is largely peripheral. A348 is positioned immediately intracellularly to the narrowest part (the gate) of the ion conducting pathway. 7 WT, H155Y or A348T mutant receptors (left column), and the rP2X 7 WT, Y155H and T348A mutant receptors (right column). Scale bar is 10 μm. B. Representative Western blots showing cell surface expression of the indicated P2X 7 proteins (biotin-labelled; top), and total expression for the indicated P2X 7 and GFP proteins (whole cell lysate; bottom). Similar results were observed in at least three independent experiments.
Fig.8 Localization of intracellular hP2X 7 proteins within the ER compartment
Representative immunofluorescent confocal images of double-staining for hP2X 7 WT proteins (red) and calreticulin (green), an ER protein marker (A), and double-staining for hP2X 7 WT proteins (red) and TGN46 (green), a trans-Golgi network protein marker (B). Scale bar is 10 μm. hP2X 7 WT 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 100 300 1000 3000 5000 30 H155R (6) H155A (5) H155F (7) hP2X 7 WT (28) H155L (5) H155Y (4) H155N ( A348T (7) A348F (4) A348G (4) A348M ( A B rP2X 7 -WT hP2X 7 A Calreticulin hP2X 7 Merged TGN46 hP2X 7 Merged
